Fibrinolysis and COVID-19: A tale of two sites?

Charithani B. Keragala; Robert L. Medcalf; Paul S. Myles

doi:10.1111/jth.15017

Fibrinolysis and COVID-19: A tale of two sites?

Charithani B. Keragala, Robert L. Medcalf, Paul S. Myles

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	2430-2432
Number of pages	3
Journal	Journal of Thrombosis and Haemostasis
Volume	18
Issue number	9
DOIs	https://doi.org/10.1111/jth.15017
Publication status	Published - Sept 2020

Keywords

coagulation
coronavirus
COVID-19
D-dimer
fibrinolysis

Access to Document

10.1111/jth.15017

320351077-oaFinal published version, 391 KB

Cite this

@article{72d0f98d9ee547409eca853ea0c2094b,

title = "Fibrinolysis and COVID-19: A tale of two sites?",

keywords = "coagulation, coronavirus, COVID-19, D-dimer, fibrinolysis",

author = "Keragala, {Charithani B.} and Medcalf, {Robert L.} and Myles, {Paul S.}",

year = "2020",

month = sep,

doi = "10.1111/jth.15017",

language = "English",

volume = "18",

pages = "2430--2432",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Fibrinolysis and COVID-19

T2 - A tale of two sites?

AU - Keragala, Charithani B.

AU - Medcalf, Robert L.

AU - Myles, Paul S.

PY - 2020/9

Y1 - 2020/9

KW - coagulation

KW - coronavirus

KW - COVID-19

KW - D-dimer

KW - fibrinolysis

UR - http://www.scopus.com/inward/record.url?scp=85089985972&partnerID=8YFLogxK

U2 - 10.1111/jth.15017

DO - 10.1111/jth.15017

M3 - Letter

C2 - 32692877

AN - SCOPUS:85089985972

SN - 1538-7933

VL - 18

SP - 2430

EP - 2432

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

IS - 9

ER -

Fibrinolysis and COVID-19: A tale of two sites?

Keywords

Access to Document

Other files and links

Improving the safety and predictable efficacy of thrombolytic therapy in acute ischaemic stroke

Improving the Impact of Perioperative Clinical Trials

Proteases and protease-inhibitor complexes as modulators of traumatic brain injury severity

Cite this

Fibrinolysis and COVID-19: A tale of two sites?

Keywords

Access to Document

Other files and links

Projects

Improving the safety and predictable efficacy of thrombolytic therapy in acute ischaemic stroke

Improving the Impact of Perioperative Clinical Trials

Proteases and protease-inhibitor complexes as modulators of traumatic brain injury severity

Cite this